Preventing Suicide and Suffering Caused by Mental Illness
Please help people who are suffering with mental illness by supporting treatment innovation in Australia.
Mind Medicine Australia is a registered charity working to alleviate the suffering and suicides caused by mental illness by expanding treatment options through the safe, clinical use of psychedelic-assisted therapies to treat depression, trauma, addictions and other intractable conditions. Please help people who are suffering with mental illness by supporting treatment innovation in Australia.
MMA is a charity registered with the Australian Charities and NFPs Commission to:
"Pursue the charitable purpose of advancing health and, principally, to promote the prevention and control of mental health diseases in humans by promoting the research, education and development of approved and evidence-based psychedelic medicines for therapeutic use" (1)
Mind Medicine Australia is not seeking in any way to encourage consumers to seek to obtain MDMA or psilocybin as a Schedule 8 medicine, seek a prescription for that medicine or seek to participate in MDMA or psilocybin assisted therapy. We are simply seeking to provide Australians with comprehensive educational content so that Australians can better understand developments in this area.
Apply now for our Certificate in Psychedelic-Assisted Therapies (CPAT)™
Secure your spot for the 2026 Intakes. Don't miss out on learning with the world's best and becoming a leader in this rapidly emerging field. Financial Assistance places are available for those who can display excellence, need and commitment.
Next cohort begins 21 February 2027. Limited spots remaining. Apply today.
Fundamentals of Psychedelic-Assisted Therapies for Mental Health
Discover how psychedelic medicine is reshaping mental health treatment. Learn the science, clinical applications, and protocols to stay at the forefront of this emerging field. This is a 6-part online training program on the Fundamentals of Psychedelic-Assisted Therapies.
The course is designed to educate a broad range of medical and mental health professionals, those with lived experience and consumers on the science and clinical use of psychedelics.
Why Psychedelic-assisted therapies are needed now
Current treatments for mental illness don't work for a large number of people and can cause nasty side effects. There is no clinical justification for the number of medications and treatments some patients receive. Please see Vanessa and Franco's Story on this short video and Vanessa's Letter to the PM:
Psychedelic-Assisted Therapies in Australia
Psilocybin and MDMA are now classified as controlled medicines in Australia when prescribed by authorised psychiatrists for treatment-resistant depression and PTSD.
In February 2023 the TGA approved Mind Medicine Australia's application to reschedule the substances psilocybin and MDMA from Schedule 9 (prohibited substances) to Schedule 8 (controlled medicines) of the Poisons Standard. With this rescheduling, psychiatrists who have the requisite approvals are now able to utilise psilocybin for treatment-resistant depression and MDMA for PTSD. These changes came into effect July 1st, 2023 and patients have been receiving treatment since January 2024.
Everyone meeting the medical criteria should be able to access psychedelic-assisted therapies in medically controlled environments
Patient Support Fund
To date, more than 250+ patients have received treatment with support from over 50 trained psychiatrists and associated clinics. Our Patient Support Fund (PSF) has begun subsidising treatment costs for patients.
Please help us to make psychedelic-assisted psychotherapies accessible for all Australians who need them.
Our Achievements
Treatments are now taking place through Authorised Prescribers.
Your donation supports:
Financial Assistance Toward Practitioner Professional Development
Supporting access for practitioners to build upon their skills. This includes our Certificate in Psychedelic-Assisted Therapies program, as well as shorter workshops to prepare mental health professionals for the future.
Awareness and Knowledge Building
We organise educational events, film screenings, conferences and also have local chapters open to the public.
Access to Medically Approved Therapy
We promote changes in legislation, promote legal and ethical frameworks, develop clinical rollouts and medicine manufacturing capabilities.
Engagement with University sector and novel research
Engagement with universities to promote research, education, development and economic analysis and rollout plans.
Supporting those who cannot afford treatments
Mind Medicine Australia has set up a Patient Support Fund (PSF) to receive donations from large to small philanthropists, and hopefully governments around Australia, to support those who cannot afford the full costs of treatments.